Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07219888
PHASE4

Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty

Sponsor: University of Louisville

View on ClinicalTrials.gov

Summary

The purpose this study is determine whether postoperative oral dosage of suzetrigine is effective at controlling postoperative pain and reducing analgesic requirements following primary total knee arthroplasty (TKA) versus a control group of TKA patients receiving postoperative Oxycodone.

Official title: Comparison of Suzetrigine and Oxycodone for Postoperative Pain and Analgesic Requirements After Primary Total Knee Arthroplasty: a Prospective, Randomized Study

Key Details

Gender

All

Age Range

21 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2025-12-01

Completion Date

2026-05-29

Last Updated

2025-10-28

Healthy Volunteers

No

Interventions

DRUG

oral suzetrigine

patient receives a two-week supply of oral suzetrigine upon discharge

DRUG

oral Oxycodone

Patient will receive a two-week supply of oral Oxycodone upon discharge